# Diabetes Treatment Guidelines

## Type 2 Diabetes Management

### First Line Therapy
- **Metformin** is the preferred initial pharmacological agent for type 2 diabetes.
- Start at 500mg daily, titrate up to 2000mg daily as tolerated.
- Continue metformin unless contraindicated or not tolerated.

### Second Line Therapy Options
1. **SGLT2 Inhibitors**
   - Empagliflozin, Dapagliflozin, Canagliflozin
   - Benefits: Cardiovascular protection, renal protection
   - Dose: Varies by specific medication

2. **GLP-1 Receptor Agonists**
   - Liraglutide, Semaglutide, Dulaglutide
   - Benefits: Weight loss, cardiovascular benefits
   - Administration: Subcutaneous injection

3. **DPP-4 Inhibitors**
   - Sitagliptin, Linagliptin, Saxagliptin
   - Benefits: Low risk of hypoglycemia
   - Dose: Once daily

### Insulin Therapy
- Consider insulin when:
  - HbA1c > 9.0%
  - Symptomatic hyperglycemia
  - Unable to achieve targets with oral agents

### Monitoring
- HbA1c every 3-6 months
- Annual eye exam
- Annual foot exam
- Regular blood pressure and lipid monitoring

## Medication Safety
- Avoid metformin in patients with eGFR < 30 mL/min/1.73mÂ²
- SGLT2 inhibitors require renal function monitoring
- GLP-1 agonists may cause gastrointestinal side effects


